Jacek Winiarski

Publications
Public outreach and news

Articles

Article: BLOOD. 2022;139(13):2066-2079
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis
Albert MH; Slatter MA; Gennery AR; Gungor T; Bakunina K; Markovitch B; Hazelaar S; Sirait T; Courteille V; Aiuti A; Aleinikova OV; Balashov D; Bernardo ME; Bodova I; Bruno B; Cavazzana M; Chiesa R; Fischer A; Hauck F; Ifversen M; Kalwak K; Klein C; Kulagin A; Kupesiz A; Kuskonmaz B; Lindemans CA; Locatelli F; Lum SH; Maschan A; Meisel R; Moshous D; Porta F; Sauer MG; Sedlacek P; Schulz A; Suarez F; Vallee TC; Winiarski JH; Zecca M; Neven B; Veys P; Lankester AC
Article: SUPPORTIVE CARE IN CANCER. 2020;28(10):4869-4879
Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial
Kamsvag T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
Article: BLOOD ADVANCES. 2020;4(15):3754-3766
Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study
Bergsten E; Horne A; Myrberg IH; Arico M; Astigarraga I; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Nanduri V; Rosso DA; Sieni E; Winiarski J; Henter J-I
Article: CLINICAL AND TRANSLATIONAL SCIENCE. 2020;13(2):293-300
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
El-Serafi I; Remberger M; Ringden O; Torlen J; Sundin M; Bjorklund A; Winiarski J; Mattsson J
Article: BLOOD ADVANCES. 2019;3(20):3123-3131
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Angel Diaz M; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gomez-Almaguer D; Gonzalez Vicent M; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldana BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1965-1969
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease
Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringden O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1970-1974
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Andersson P-O; Brune M
Article: TRANSPLANTATION. 2019;103(6):1247-1252
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor
Ringden O; Remberger M; Gustafsson B; Moretti G; Mattsson J; Winiarski J; Sadeghi B
Article: BONE MARROW TRANSPLANTATION. 2019;54(5):726-736
Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study
Wilhelmsson M; Glosli H; Ifversen M; Abrahamsson J; Winiarski J; Jahnukainen K; Hasle H
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;184(6):982-993
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience
Ifversen M; Turkiewicz D; Marquart HV; Winiarski J; Buechner J; Mellgren K; Arvidson J; Rascon J; Korgvee L-T; Madsen HO; Abrahamsson J; Lund B; Jonsson OG; Heilmann C; Heyman M; Schmiegelow K; Vettenranta K
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2018;107(11):1995-2003
Children with mucopolysaccharidosis risk progressive visual dysfunction despite haematopoietic stem cell transplants
Fahnehjelm KT; Olsson M; Chen E; Hengstler J; Naess K; Winiarski J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(6):613-620
Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia A Swedish nationwide cohort study
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2018;7(4):325-331
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
Article: PEDIATRIC TRANSPLANTATION. 2018;22(2)
Visual perceptual skills and visual motor integration in children and adolescents after allogeneic hematopoietic stem cell transplantation
Fahnehjelm KT; Tornquist AL; Olsson M; Winiarski J; Ek U
Article: HAEMATOLOGICA. 2017;102(10):1683-1690
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011
Vaht K; Goransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson P-O
Journal article: INTERNATIONAL JOURNAL OF NEONATAL SCREENING. 2017;3(2):11
Newborn Screening for Primary Immune Deficiencies with a TREC/KREC/ACTB Triplex Assay—A Three-Year Pilot Study in Sweden
Zetterström RH; Barbaro M; Ohlsson A; Borte S; Jonsson S; Winiarski J; von Döbeln U; Hammarström L
Article: CLINICAL IMMUNOLOGY. 2017;176:71-76
NEIL1 is a candidate gene associated with common variable immunodeficiency in a patient with a chromosome 15q24 deletion
Romano R; Zaravinos A; Liadaki K; Caridha R; Lundin J; Carlsson G; Winiarski J; Pan-Hammarstrom Q; Hammarstrom L
Article: CLINICAL NEUROPHYSIOLOGY PRACTICE. 2017;2:67-71
Visual evoked potentials after hematopoietic allogeneic stem cell transplantation in childhood.
Törnquist AL; Andersson T; Winiarski J; Grönlund MA; Fahnehjelm KT
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2017;37(1):51-60
Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterstrom RH; King J; Winiarski J; von Dobeln U; Hammarstrom L
Article: HAEMATOLOGICA. 2016;101(11):1417-1425
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2016;20(5):667-674
Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades
Svenberg P; Remberger M; Uzunel M; Mattsson J; Gustafsson B; Fjaertoft G; Sundin M; Winiarski J; Ringden O
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2016;36(5):480-489
Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation
Tesi B; Priftakis P; Lindgren F; Chiang SCC; Kartalis N; Lofstedt A; Lorinc E; Henter J-I; Winiarski J; Bryceson YT; Meeths M
Article: ONCOTARGET. 2016;7(21):30230-30240
Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning
Li Q; Rane L; Poiret T; Zou J; Magalhaes I; Ahmed R; Du Z; Vudattu N; Meng Q; Gustafsson-Jernberg A; Winiarski J; Ringden O; Maeurer M; Remberger M; Ernberg I
Article: PEDIATRIC TRANSPLANTATION. 2016;20(1):96-104
HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT
Thorvaldson L; Remberger M; Winiarski J; Omazic B; Fischler B; Sundin M
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2016;105(1):82-89
Cataract after allogeneic hematopoietic stem cell transplantation inchildhood
Fahnehjelm KT; Tornquist AL; Olsson M; Backstrom I; Gronlund MA; Winiarski J
Article: PEDIATRIC TRANSPLANTATION. 2015;19(7):758-766
Chimerism analysis in clinical practice and its relevance for the detection of graft rejection and malignant relapse in pediatric hematopoietic stem cell transplant patients
Mellgren K; Arvidson J; Toporski J; Winiarski J
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2015;174(6):801-807
Neutropenia in childhood: a 5-year experience at a tertiary center
Lindqvist H; Carlsson G; Moell J; Winiarski J; Sundin M
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):850-857
Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up
Wilhelmsson M; Vatanen A; Borgstrom B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Article: PEDIATRIC BLOOD AND CANCER. 2015;62(5):890-896
Hypogammaglobulinemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Cytokine Mediated Immunoglobulin Isotype Class Switch Arrest?
Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;169(1):103-110
Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases
Tucunduva L; Volt F; Cunha R; Locatelli F; Zecca M; Yesilipek A; Caniglia M; Guengoer T; Aksoylar S; Fagioli F; Bertrand Y; Addari MC; de la Fuente J; Winiarski J; Biondi A; Sengeloev H; Badell I; Mellgren K; de Heredia CD; Sedlacek P; Vora A; Rocha V; Ruggeri A; Gluckman E
Article: CLINICAL IMMUNOLOGY. 2014;155(1):74-78
Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndrome
Borte S; Fasth A; von Dobeln U; Winiarski J; Hammarstrom L
Article: PSYCHO-ONCOLOGY. 2014;23(11):1307-1313
Patterns of psychological responses in parents of children that underwent stem cell transplantation
Riva R; Forinder U; Arvidson J; Mellgren K; Toporski J; Winiarski J; Norberg AL
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(10):1646-1649
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.
Blennow O; Fjaertoft G; Winiarski J; Ljungman P; Mattsson J; Remberger M
Article: JOURNAL OF IMMUNOTHERAPY. 2014;37(8):416-425
TCR⁺CD4^-CD8^- T cells in Antigen-specific MHC Class I-restricted T-cell Responses After Allogeneic Hematopoietic Stem Cell Transplantation
Ahmed RK; Poiret T; Ambati A; Rane L; Remberger M; Omazic B; Vudattu NK; Winiarski J; Ernberg I; Axelsson-Robertson R; Magalhaes I; Castelli C; Ringden O; Maeurer M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(10):1537-1543
Vitamin D Levels Affect Outcome in Pediatric Hematopoietic Stem Cell Transplantation
Hansson MEA; Norlin A-C; Omazic B; Wikstrom A-C; Bergman P; Winiarski J; Remberger M; Sundin M
Article: BMC IMMUNOLOGY. 2014;15:25
Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
Poiret T; Rane L; Remberger M; Omazic B; Gustafsson-Jernberg A; Vudattu NK; Ahmed R; Ernberg I; Winiarski J; Magalhaes I; Ringden O; Maeurer M
Article: PEDIATRIC BLOOD AND CANCER. 2014;61(6):1094-1100
Adult Testicular Volume Predicts Spermatogenetic Recovery After Allogeneic HSCT in Childhood and Adolescence
Wilhelmsson M; Vatanen A; Borgstrom B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2014;34(4):469-477
Novel STAT3 Mutation Causing Hyper-IgE Syndrome: Studies of the Clinical Course and Immunopathology
Sundin M; Tesi B; Bohme MS; Bryceson YT; Putsep K; Chiang SC; Thunberg S; Winiarski J; Wikstorm A-C
Article: PEDIATRIC TRANSPLANTATION. 2014;18(3):302-309
Relationship between problems related to child late effects and parent burnout after pediatric hematopoietic stem cell transplantation
Lindahl Norberg A; Mellgren K; Winiarski J; Forinder U
Article: ACTA OPHTHALMOLOGICA. 2014;92(2):171-178
Ocular manifestations and visual functions in patients with Fanconi anaemia
Tornquist AL; Martin L; Winiarski J; Fahnehjelm KT
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2014;170(2):211-218
Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence
Vatanen A; Wilhelmsson M; Borgstrom B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Article: HAEMATOLOGICA. 2014;99(2):346-352
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2013;102(11):1087-1094
Chronic granulomatous disease - haematopoietic stem cell transplantation versus conventional treatment
Ahlin A; Fugelang J; de Boer M; Ringden O; Fasth A; Winiarski J
Article: BLOOD. 2013;121(8):1345-1356
Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production
Chiang SCC; Theorell J; Entesarian M; Meeths M; Mastafa M; Al-Herz W; Frisk P; Gilmour KC; Ifversen M; Langenskiold C; Machaczka M; Naqvi A; Payne J; Perez-Martinez A; Sabel M; Unal E; Unal S; Winiarski J; Nordenskjold M; Ljunggren H-G; Henter J-I; Bryceson YT
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2013;19(2):325-328
Folinic Acid Supplementation in Higher Doses is Associated with Graft Rejection in Pediatric Hematopoietic Stem Cell Transplantation
Lindqvist H; Remberger M; Harila-Saari A; Winiarski J; Sundin M
Article: PEDIATRIC TRANSPLANTATION. 2012;16(8):866-871
Subcutaneous IgG replacement after pediatric SCT
Sundin M; Nordin K; Jostemyr Y; Winiarski J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(12):1776-1784
Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research
Buchbinder D; Nugent DJ; Brazauskas R; Wang Z; Aljurf MD; Cairo MS; Chow R; Duncan C; Eldjerou LK; Gupta V; Hale GA; Halter J; Hayes-Lattin BM; Hsu JW; Jacobsohn DA; Kamble RT; Kasow KA; Lazarus HM; Mehta P; Myers KC; Parsons SK; Passweg JR; Pidala J; Reddy V; Sales-Bonfim CM; Savani BN; Seber A; Sorror ML; Steinberg A; Wood WA; Wall DA; Winiarski JH; Yu LC; Majhail NS
Article: TRANSPLANTATION. 2012;94(10):1066-1074
Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2012;16(6):E241-E245
Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia
Gustafsson B; Moell J; LeBlanc K; Barbany G; Soderhall S; Winiarski J
Article: ACTA OPHTHALMOLOGICA. 2012;90(5):445-448
Corneal hysteresis in mucopolysaccharidosis I and VI
Fahnehjelm KT; Chen E; Winiarski J
Article: ACTA OPHTHALMOLOGICA. 2012;90(3):287-290
Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler)
Fahnehjelm KT; Tornquist AL; Winiarski J
Article: THE LANCET. 2012;379(9823):1301-1309
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Mueller I; Stein J; Wynn R; Greil J; Sykora K-W; Matthes-Martin S; Fuehrer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Koerholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin K-M; Peters C; Dini G
Article: BLOOD. 2012;119(11):2552-2555
Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR
Borte S; von Dobeln U; Fasth A; Wang N; Janzi M; Winiarski J; Sack U; Pan-Hammarstrom Q; Borte M; Hammarstrom L
Article: PLOS ONE. 2012;7(8):e43419
Placental Transfer of Maternally-Derived IgA Precludes the Use of Guthrie Card Eluates as a Screening Tool for Primary Immunodeficiency Diseases
Borte S; Janzi M; Pan-Hammarstrom Q; von Dobeln U; Nordvall L; Winiarski J; Fasth A; Hammarstrom L
Article: BLOOD. 2011;118(22):5783-5793
Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D
Meeths M; Chiang SCC; Wood SM; Entesarian M; Schlums H; Bang B; Nordenskjold E; Bjorklund C; Jakovljevic G; Jazbec J; Hasle H; Holmqvist B-M; Rajic L; Pfeifer S; Rosthoj S; Sabel M; Salmi TT; Stokland T; Winiarski J; Ljunggren H-G; Fadeel B; Nordenskjold M; Henter J-I; Bryceson YT
Article: PEDIATRIC TRANSPLANTATION. 2011;15(7):691-698
The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood
Lof CM; Winiarski J; Ljungman P; Forinder U
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2011;46(3):372-378
Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse
Rubin J; Vettenranta K; Vettenranta J; Bierings M; Abrahamsson J; Bekassy AN; Hakansson Y; Frost B-M; Arvidson J; Spendilow C; Winiarski J; Gustafsson B
Article: PEDIATRIC BLOOD AND CANCER. 2011;56(3):444-451
Hematopoietic Stem Cell Transplantation in Severe Congenital Neutropenia
Carlsson G; Winiarski J; Ljungman P; Ringden O; Mattsson J; Nordenskjold M; Touw I; Henter J-I; Palmblad J; Fadeel B; Hagglund H
Article: ACTA OPHTHALMOLOGICA. 2011;89(1):62-69
Visual field results and optic disc morphology in patients treated with allogeneic stem-cell transplantation in childhood
Tornquist AL; Olsson M; Martin L; Winiarski J; Fahnehjelm KT
Article: BLOOD. 2009;114(19):4117-4127
Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity
Wood SM; Meeths M; Chiang SCC; Bechensteen AG; Boelens JJ; Heilmann C; Horiuchi H; Rosthoj S; Rutynowska O; Winiarski J; Stow JL; Nordenskjold M; Henter J-I; Ljunggren H-G; Bryceson YT
Article: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):393-399
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
Omar H; Hagglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 2009;43(6):461-468
Health-related quality of life in adult survivors after paediatric allo-SCT
Lof CM; Winiarski J; Giesecke A; Ljungman P; Forinder U
Article: BONE MARROW TRANSPLANTATION. 2008;42(8):515-522
Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning
Smedler A-C; Winiarski J
Article: SOCIAL WORK IN HEALTH CARE. 2008;47(2):157-173
Long-term psychosocial support for families of children who have undergone allogeneic stem cell transplant
Forinder U; Posse E; Winiarski J
Journal article: ACTA OPHTHALMOLOGICA. 2008;86(3):253-258
Dry-eye syndrome after allogeneic stem-cell transplantation in children
Fahnehjelm KT; Törnquist A-L; Winiarski J
Article: ACTA OPHTHALMOLOGICA. 2008;86(3):253-258
Dry-eye syndrome after allogeneic stem-cell transplantation in children
Fahnehjelm KT; Tornquist A-L; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2008;41(8):737-742
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts
Giraud G; Priftakis P; Bogdanovic G; Remberger M; Dubrulle M; Hau A; Gutmark R; Mattson J; Svahn B-M; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2008;41(7):621-625
Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population:: A comparative study between the standard 4-dose and a 2-dose regimen
Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Winiarski J; Ringden O; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2007;40(11):1055-1062
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Article: ACTA OPHTHALMOLOGICA. 2007;85(7):724-733
Visual outcome and cataract development after allogeneic stem-cell transplantation in children
Fahnehjelm KT; Tornquist A-L; Olsson M; Winiarski J
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2007;96(11):1660-1664
Acquired aplastic anaemia in seven children with severe hepatitis with or without liver failure
Honkaniemi E; Gustafsson B; Fischler B; Nemeth A; Frost B-M; Papadogiannakis N; Winiarski J
Article: BLOOD. 2007;110(6):1906-1915
Defective cytotoxic lymphocyte degranulation in syntaxin-11-deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients
Bryceson YT; Rudd E; Zheng C; Edner J; Ma D; Wood SM; Bechensteen AG; Boelens JJ; Celkan T; Farah RA; Hultenby K; Winiarski J; Roche PA; Nordenskjold M; Henter J-I; Long EO; Ljunggren H-G
Article: BONE MARROW TRANSPLANTATION. 2007;39(11):717-723
Long-term renal function following bone marrow transplantation
Gronroos MH; Bolme P; Winiarski J; Berg UB
Article: BONE MARROW TRANSPLANTATION. 2007;39(7):383-388
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
Ringden O; Remberger M; Svenberg P; Svahn B-M; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Article: PEDIATRIC TRANSPLANTATION. 2007;11(2):145-151
Risk factors for lower health-related QoL after allogeneic stem cell transplantation in children
Lof CM; Forinder U; Winiarski J
Article: ACTA OPHTHALMOLOGICA. 2006;84(6):781-785
Ocular findings in four children with mucopolysaccharidosis I-Hurler (MPS I-H) treated early with haematopoietic stem cell transplantation
Fahnehjelm KT; Tornquist A-L; Malm G; Winiarski J
Article: PEDIATRIC TRANSPLANTATION. 2006;10(4):491-496
Quality of life following allogeneic stem cell transplantation, comparing parents' and children's perspective
Forinder U; Lof C; Winiarski J
Article: TRANSPLANTATION. 2006;81(5):718-725
Allogeneic hematopoietic stem cell transplantation for inherited disorders:: Experience in a single center
Ringdén O; Remberger M; Svahn BM; Barkholt L; Mattsson J; Aschan J; Le Blanc K; Gustafsson B; Hassan Z; Omazic B; Svenberg P; Solders G; von Döbeln U; Winiarski J; Ljungman P; Malm G
Article: HAEMATOLOGICA. 2006;91(3):401-404
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen
Giraud G; Bogdanovic G; Priftakis P; Remberger M; Svahn B-M; Barkholt L; Ringden O; Winiarski J; Ljungman P; Dalianis T
Article: HAEMATOLOGICA. 2006;91(1):78-83
Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation
Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringden O
Journal article: BLOOD. 2005;106(11):3239
Fatal Infectious Complications Developing Late after Allogeneic Stem Cell Transplantation.
Bjorklund A; Aschan J; Ringden O; Winiarski JH; Ljungman PT
Article: BONE MARROW TRANSPLANTATION. 2005;36(2):171-176
Quality of life and health in children following allogeneic SCT
Forinder U; Lof C; Winiarski J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2005;129(5):622-630
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis
Horne A; Janka G; Egeler RM; Gadner H; Imashuku S; Ladisch S; Locatelli F; Montgomery SM; Webb D; Winiarski J; Filipovich AH; Henter JI
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(12):877-882
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors
Svenberg P; Remberger M; Svennilson J; Mattsson J; Leblanc K; Gustafsson B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2004;34(12):1067-1069
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients
Ljungman P; Aschan J; Gustafsson B; Lewensohn-Fuchs I; Winiarski J; Ringdén O
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2004;42(11):5394-5396
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation
Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Ferraldeschi R; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Article: PEDIATRIC TRANSPLANTATION. 2004;8(5):464-474
Risk factors in pediatric stem cell transplantation for leukemia
Jernberg Å; Remberger M; Ringdén O; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2004;34(7):589-593
Measles immunity after allogeneic stem cell transplantation;: influence of donor type, graft type, intensity of conditioning, and graft-versus host disease
Ljungman P; Aschan J; Barkholt L; Broliden PA; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
Article: TRANSPLANTATION. 2004;78(3):415-419
Five-year follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors
Malm G; Månsson JE; Winiarski J; Mosskin M; Ringdén O
Article: TRANSPLANTATION. 2004;77(4):526-531
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus
Larsson K; Aschan J; Remberger M; Ringdén O; Winiarski J; Ljungman P
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2003;82(9):803-806
Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period
Tiblad E; Olsson I; Petersson K; Shanwell A; Winiarski J; Wolff K; Westgren M
Article: PEDIATRIC BLOOD AND CANCER. 2003;40(4):219-223
Human polyomavirus DNA is not detected in guthrie cards (dried blood spots) from children who developed acute lymphoblastic leukemia
Priftakis P; Dalianis T; Carstensen J; Samuelsson U; Lewensohn-Fuchs I; Bogdanovic G; Winiarski J; Gustafsson B
Article: BONE MARROW TRANSPLANTATION. 2003;31(3):175-181
Graft-versus-leukaemia effect in children:: chronic GVHD has a significant impact on relapse and survival
Jernberg Å; Remberger M; Ringdén O; Winiarski J
Article: PEDIATRIC TRANSPLANTATION. 2003;7(1):31-37
Megakaryocyte chimerism after allogeneic stem cell transplantation in children
Eklund O; Dalianis T; Wester D; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2002;30(12):833-841
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation:: 500 mg/m² as a optimal total dose for conditioning
Hassan M; Nilsson C; Hassan Z; Gungor T; Aschan J; Winiarski J; Hentschke P; Ringdén O; Eber S; Seger R; Ljungman P
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2002;91(8):974-977
Findings in familial haemophagocytic lymphohistiocytosis prior to symptomatic presentation
Hafsteinsdóttir S; Jónmundsson GK; Kristinsson JR; Winiarski J; Henter JI; Haraldsson A
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2001;18(8):497-508
MDM2 and p53 in childhood acute lymphoblastic leukemia: Higher expression in childhood leukemias with poor prognosis compared to long-term survivors
Gustafsson B; Axelsson B; Gustafsson B; Christensson B; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):479-485
Pharmacokinetics of liposomal busulphan in man
Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley HR; Hassan M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(1):50-56
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation
Remberger M; Aschan J; Lönnqvist B; Carlens S; Gustafsson B; Hentschke P; Klaesson S; Mattsson J; Ljungman P; Ringdén O
Article: PEDIATRIC TRANSPLANTATION. 2000;4(2):132-139
Follow-up of chimerism, including T- and B-lymphocytes and granulocytes in children more than one year after allogeneic bone marrow transplantation.
Winiarski J; Gustafsson A; Wester D; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 2000;25(10):1059-1065
Unrelated bone marrow transplantation in children:: outcome and a comparison with sibling donor grafting
Gustafsson Å; Remberger M; Winiarski J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2000;25(8):843-851
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Article: TRANSPLANTATION. 2000;69(5):822-826
Subjective xerostomia in long-term surviving children and adolescents after pediatric bone marrow transplantation
Bågesund M; Winiarski J; Dahllöf G
Article: BLOOD. 2000;95(3):807-814
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease:: prophylactic infusion of EBV-specific cytotoxic T cells
Gustafsson Å; Levitsky V; Zou JZ; Frisan T; Dalianis T; Ljungman P; Ringden O; Winiarski J; Ernberg I; Masucci MG
Article: PEDIATRIC BLOOD AND CANCER. 2000;34(2):117-124
Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis
Gustafsson B; Christenson B; Gustafsson B; Hjalmar V; Winiarski J
Article: NATURE GENETICS. 1999;21(1):84-90
Mutations in the gene encoding B1 subunit of H⁺-ATPase cause renal tubular acidosis with sensorineural deafness
Karet FE; Finberg KE; Nelson RD; Nayir A; Mocan H; Sanjad SA; Rodriguez-Soriano J; Santos F; Cremers CWRJ; Di Pietro A; Hoffbrand BI; Winiarski J; Bakkaloglu A; Ozen S; Dusunsel R; Goodyer P; Hulton SA; Wu DK; Skvorak AB; Morton CC; Cunningham MJ; Jha V; Lifton RP
Article: TRANSPLANTATION. 1998;66(10):1330-1334
Results of different strategies for reducing:: Cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients
Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
Article: PEDIATRIC TRANSPLANTATION. 1998;2(4):288-293
Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children.
Bogdanovic G; Priftakis P; Taemmeraes B; Gustafsson A; Flaegstad T; Winiarski J; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 1998;22(8):755-761
Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Article: TRANSPLANTATION. 1998;66(5):620-625
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including, anti-T-cell antibodies
Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
Article: BONE MARROW TRANSPLANTATION. 1998;22(1):73-78
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation
Remberger M; Ringdén O; Ljungman P; Hägglund H; Winiarski J; Lönnqvist B; Aschan J
Article: PEDIATRIC TRANSPLANTATION. 1998;2(2):150-156
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
Article: TRANSPLANTATION. 1997;64(8):1207,1208
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation on for non-A, non-B, non-C hepatitis
Hagglund H; Winiarski J; Ringden O; Sparrelid E; Ericzon BG
Article: BONE MARROW TRANSPLANTATION. 1997;19(9):905-908
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
Sparrelid E; Ljungman P; EkelofAndstrom E; Aschan J; Ringden O; Winiarski J; Wahlin B; Andersson J
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 1997;86(5):484-492
Treatment of adrenoleukodystrophy with bone marrow transplantation
Malm G; Ringden O; Anvret M; vonDobeln U; Hagenfeldt L; Isberg B; Knuutila S; Nennesmo I; Winiarski J; Marcus C
Article: TRANSPLANTATION. 1996;62(8):1076-1080
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ericzon BG; Duraj F; Ljungman P; Lonnqvist B; Winiarski J; Tyden G
Article: CLINICAL INFECTIOUS DISEASES. 1996;23(1):167-169
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation
Ljungman P; Andersson J; Aschan J; Bjorkstrand B; Hagglund H; Lonnqvist B; Ringden O; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1996;17(6):1003-1008
Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow-transplantation
Malm G; Ringden O; Winiarski J; Grondahl E; Uvebrant P; Eriksson U; Hakansson H; Skjeldal O; Mansson JE
Article: BONE MARROW TRANSPLANTATION. 1996;17(4):583-587
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients
Ljungman P; Lore K; Aschan J; Klaesson S; LewensohnFuchs I; Lonnqvist B; Ringden O; Winiarski J; Ehrnst A
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1996;56(4):230-234
Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes
Arfors L; Winiarski J; Lefvert AK
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 1996;85(3):327-335
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital
Winiarski J; Ringden O; Remberger M; Dalianis T; Ljungman P; Borgstrom B
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 1996;85(2):168-172
Fungal pneumonia: The predominant lung infection causing death in children undergoing bone marrow transplantation
Heurlin N; Bergstrom SE; Winiarski J; Ringden O; Ljungman P; Lonnqvist B; Andersson J
Article: TRANSPLANTATION. 1995;60(11):1225-1230
Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Klaesson S; Ringden O; Ljungman P; Aschan J; Hagglund H; Winiarski J
Article: BLOOD. 1995;86(4):1614-1618
LONG-TERM EFFECTS OF HEPATITIS-C VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
LJUNGMAN P; JOHANSSON N; ASCHAN J; GLAUMANN H; LONNQVIST B; RINGDEN O; SPARRELID E; SONNERBORG A; WINIARSKI J; GAHRTON G
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625
SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B AND HLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS
RINGDEN O; REMBERGER M; PERSSON U; LJUNGMAN P; ALDENER A; ANDSTROM E; ASCHAN J; BOLME P; DAHLLOF G; DALIANIS T; GAHRTON G; HAGGLUND H; LONNQVIST B; OLERUP O; SHANWELL A; SPARRELID E; WINIARSKI J; MOLLER E; OBERG M
Article: LAKARTIDNINGEN. 1995;92(9):860-864
[Thrombocytopenia in pregnant women and newborn infants. An appeal for a common care program].
Elinder G; Bremme C; Olsson I; Shanwell A; Wegnelius G; Westgren M; Winiarski J
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):331-335
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN SWEDEN
BOLME P; HENTER JI; WINIARSKI J; ELINDER G; LJUNGMAN P; LONNERHOLM G; RINGDEN O
Journal article: LAKARTIDNINGEN. 1991;88(25):2308-2311
[Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life].
Ljungman P; Aschan J; Bolme P; Lindqvist R; Lönnqvist B; Ringdén O; Winiarski J; Gahrton G
Journal article: BONE MARROW TRANSPLANTATION. 1991;7(2):113-119
METHOTREXATE COMBINED WITH CYCLOSPORINE-A DECREASES GRAFT-VERSUS-HOST DISEASE, BUT INCREASES LEUKEMIC RELAPSE COMPARED TO MONOTHERAPY
ASCHAN J; RINGDEN O; SUNDBERG B; GAHRTON G; LJUNGMAN P; WINIARSKI J
Journal article: TRANSPLANTATION PROCEEDINGS. 1990;22(1):198-202
BONE-MARROW TRANSPLANTATION FOR METABOLIC DISORDERS AT HUDDINGE-HOSPITAL
RINGDEN O; GROTH CG; ASCHAN J; BOLME P; LJUNGMAN P; LONNQVIST B; MALM G; MANSSON JE; SHANWELL A; SVENNERHOLM L; TOLLEMAR J; WINIARSKI J
Journal article: ARCHIVES OF DISEASE IN CHILDHOOD. 1990;65(1):137-139
PLATELET ANTIGENS IN VARICELLA ASSOCIATED THROMBOCYTOPENIA
WINIARSKI J
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1989;73(1):88-92
IGG AND IGM ANTIBODIES TO PLATELET MEMBRANE GLYCOPROTEIN ANTIGENS IN ACUTE CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1989;43(1):29-34
ANTIBODIES TO PLATELET MEMBRANE GLYCOPROTEIN ANTIGENS IN 3 CASES OF INFECTIOUS MONONUCLEOSIS-INDUCED THROMBOCYTOPENIC PURPURA
WINIARSKI J
Journal article: TRANSPLANTATION PROCEEDINGS. 1988;20(3):487-490
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHILDREN AT HUDDINGE-HOSPITAL
RINGDEN O; BOLME P; LONNQVIST B; TOLLEMAR J; BORGSTROM B; DOHLHOF G; LUNDGREN G; WINIARSKI J; GAHRTON G; GROTH CG
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1986;37(3):175-179
IMMUNOLOGICAL EFFECTS OF INTRAVENOUS GAMMA-GLOBULIN TREATMENT IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J; ELINDER G
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1986;63(2):459-465
ANTIBODY-BINDING TO PLATELET ANTIGENS IN ACUTE AND CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA - A PLATELET MEMBRANE ELISA FOR THE DETECTION OF ANTIPLATELET ANTIBODIES IN SERUM
WINIARSKI J; EKELUND E
Journal article: BLUT. 1985;51(4):259-266
IMMUNOGLOBULIN BINDING TO PLATELETS - THE EFFECT OF AGGREGATED IGG
WINIARSKI J
Journal article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 1984;1(1):207-211
Platelet associated IgM in acute idiopathic thrombocytopenic purpura. High-dose intravenous IgG compared to prednisolone
Winiarski J
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1983;31(4):342-348
HIGH-DOSE INTRAVENOUS IGG REDUCES PLATELET ASSOCIATED IMMUNOGLOBULINS AND COMPLEMENT IN IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J; KREUGER A; EJDERHAMN J; HOLM G
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1983;53(1):201-207
PLATELET ASSOCIATED IMMUNOGLOBULINS AND COMPLEMENT IN IDIOPATHIC THROMBOCYTOPENIC PURPURA
WINIARSKI J; HOLM G
Journal article: OBSTETRICAL AND GYNECOLOGICAL SURVEY. 1981;36(7):356-357
Premature Rupture of the Membranes
EVALDSON G; LAGRELIUS A; WINIARSKI J
Journal article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 1980;59(5):385-393
PREMATURE RUPTURE OF THE MEMBRANES
EVALDSON G; LAGRELIUS A; WINIARSKI J
Show more

All other publications

Review: STEM CELLS. 2024;42(4):291-300
Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease
Ringden O; Sadeghi B
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(3):E74-E77
Hospitalizations in long-term survivors of childhood AML treated with allogeneic HCT-An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
Wilhelmsson M; Jahnukainen K; Winiarski J; Abrahamsson J; Bautz A; Gudmundsdottir T; Madanat-Harjuoja L-M; Holmqvist AS; Winther JF; Hasle H
Conference publication: CYTOTHERAPY. 2019;21(5):S74
LONG-TERM FOLLOW UP OF A PILOT STUDY USING PLACENTA DERIVED DECIDUA STROMAL CELLS FOR SEVERE ACUTE GRAFT VERSUS HOST DISEASES
Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Kingspor L; Westgren M; Mattsson J; Ringden O
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(3):s247
Long Term Follow-up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-Versus-Host Disease
Ringden O; Remberger M; Gustafsson B; Winiarski J; Khoein B; Klingspor L; Westgren M; Mattsson J; Sadeghi B
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(3):s16
Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen for Patients with Wiskott-Aldrich Syndrome - an EBMT Inborn Errors Working Party and Scetide Study
Albert MH; Slatter M; Gennery A; Gungor T; Blok H-J; Hazelaar S; Wang J; Courteille V; Mahlaoui N; Bernado ME; Bodova I; Bruno B; Bykova T; Chiesa R; Fischer A; Formankova R; Kalwak K; Klein C; Kozlovskaya S; Kupesiz A; Locatelli F; Moshous D; Neven B; Porta F; Schulz A; Sykora K-W; Karakukcu M; Winiarski J; Zecca M; Veys P; Lankester AC
Conference publication: BONE MARROW TRANSPLANTATION. 2019;54:300
Long term follow-up of a pilot study using placenta-derived decidua stromal cells for severe acute graft-versus-host disease
Ringden O; Remberger M; Gustafsson B; Winiarski J; Khoein B; Klingspor L; Westgren M; Mattsson J; Sadeghi B
Conference publication: BLOOD. 2018;132:2175
Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen in Patients with Wiskott-Aldrich Syndrome Given Allogeneic Hematopoietic Cell Transplantation - an EBMT Inborn Errors Working Party and Scetide Retrospective Analysis
Albert MH; Slatter M; Gennery A; Guengoer T; Blok H-J; Wang J; Courteille V; Bernardo ME; Bodova I; Bruno B; Bykova TA; Chiesa R; Fischer A; Formankova R; Kalwak K; Klein C; Kozlovskaya S; Kupesiz OA; Locatelli F; Mahlaoui N; Moshous D; Neven B; Porta F; Schulz A; Sykora K-W; Unal E; Winiarski JH; Zecca M; Veys P; Lankester A
Conference publication: BONE MARROW TRANSPLANTATION. 2018;53:347-348
Long-term health outcomes and fertility in survivors of childhood AML treated with allogeneic HSCT: A NOPHO-AML Study
Wilhelmsson M; Glosli H; Ifversen M; Abrahamsson J; Winiarski J; Jahnukainen K; Hasle H
Conference publication: PEDIATRIC BLOOD AND CANCER. 2018;65:S232-S233
Burden of Hospitalizations in Long-Term Survivors of Childhood AML Treated with Allogeneic-HSCT: An ALiCCs Study
Wilhelmsson M; Winiarski J; Winther JF; Gudmundsdottir T; Madanat-Harjuoja L; Olsen JH; Jahnukainen K; Hasle H
Letter: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2017;139(5):1713-1716.e6
Costs associated with treatment of severe combined immunodeficiency-rationale for newborn screening in Sweden
Gardulf A; Winiarski J; Thorin M; Arnlind MH; von Dobeln U; Hammarstrom L
Conference publication: PEDIATRIC BLOOD AND CANCER. 2017;64:S360-S361
Oral Cryotherapy to Reduce the Incidence of Severe Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation: Results of a Randomized Clinical Trial
Magnusson TK; von Essen L; Arvidson J; Svanberg A; Mellgren K; Garming-Legert K; Toporski J; Winiarski J; Ljungman G
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):S48
Placenta-Derived Decidual Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
Ringden O; Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustavsson B; Winiarski J; Westgren M; Sadeghi B; Mattsson J; Kaipe H
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S21
A prospective randomized study comparing tacrolimus and sirolimus versus cyclosporine and methotrexate as gvhd prophylaxis in allogeneic hematopoietic stem cell transplantation
Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Conference publication: TRANSPLANTATION. 2016;100(7):S438
Placenta-derived decidual stromal cells for treatment of severe acute graft-versus-host disease
Ringden O; Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustafsson B; Winiarski J; Westgren M; Sadeghi B; Kaipe H
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S377
Placenta-derived decidual stromal cells for treatment of severe acute graft-versus-host disease
Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustafsson B; Winiarski J; Sadeghi B; Kaipe H; Ringden O
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(2):S173
Superior Survival Rate Following Conditioning with Etoposide in Childhood ALL
Ifversen M; Winiarski J; Saarinen-Pihkala U; Mellgren K; Glomstein A; Arvidson J; Lahtenmaaki P; Toporski J; Rosthoej S; Heyman M; Heilmann C
Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S264-S265
SIGNIFICANTLY REDUCED RISK OF SINUSOIDAL OBSTRUCTION SYNDROME OF THE LIVER IN RECENT YEARS IN PATIENTS RECEIVING BUCY PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Mattsson J; Ringden O; Engstrom M; Berglund S; Ljungman P; Winiarski J; Uhlin M; Svahn B-M; Remberger M; Hassan M
Meeting abstract: BLOOD. 2013;122(21):5483
The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation
Hansson MEA; Norlin A-C; Omazic B; Wikstroem A-C; Winiarski J; Remberger M; Sundin M
Meeting abstract: BLOOD. 2013;122(21):5473
Hypogammaglobulinemia In Children Undergoing SCT: A Immunoglobulin Isotype Class Switch Arrest?
Lindqvist H; Remberger M; Sundberg B; Uzunel M; Winiarski J; Sundin M
Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S301
Varicella zoster virus disease after allogeneic haematopoietic stem cell transplantation. Incidence, risk factors and complications
Fjaertoft G; Winiarski J; Ljungman P; Uhlin M; Remberger M; Mattsson J
Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S48
Risk factors for Epstein Barr virus-related post-transplant lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation
Uhlin M; Wikell H; Sundin M; Blennow O; Mauerer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Conference publication: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S226
LATE EFFECTS IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS WITH ACQUIRED SEVERE APLASTIC ANEMIA: A REPORT FROM THE LATE EFFECTS WORKING COMMITTEE OF THE CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH (CIBMTR)
Buchbinder D; Nugent D; Brazauskas R; Wang Z; Aljurf M; Cairo MS; Chow R; Duncan C; Eldjerou LK; Gupta V; Hale GA; Halter J; Hayes-Lattin BM; Hsu JW; Jacobsohn DA; Kamble RT; Kasow KA; Lazarus HM; Mehta P; Myers KC; Parsons SK; Passweg JR; Pidala J; Reddy V; Sales-Bonfim CM; Savani BN; Seber A; Sorror ML; Steinberg A; Wood WA; Wall DA; Winiarski JH; Yu LC; Majhail NS
Conference publication: JOURNAL OF CLINICAL IMMUNOLOGY. 2012;32:252
COMBINED NEONATAL SCREENING FOR SCID AND XLA USING TRECS AND KRECS
Borte S; von Dobeln U; Fasth A; Wang N; Janzi M; Winiarski J; Pan-Hammarstrom Q; Sack U; Borte M; Hammarstrom L
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S142-S143
Changes in allogeneic haematopoietic stem cell transplantation in children during the last two decades
Svenberg P; Remberger M; Gustafsson B; Hassan Z; Mattsson J; Winiarski J; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S167-S168
Improved survival after allogeneic haematopoietic stem cell transplantation in recent years
Ringden O; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Remberger M
Review: LAKARTIDNINGEN. 2010;107(42):2576-2580
[Transplantation gives severely ill children a chance to life].
Németh A; Berg U; Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 2010;45:S1
Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Boelens JJ; Uderzo C; Hewitt N; Rovelli A; Schrum J; Mueller I; Schulz A; Stein J; Wynn R; Greil J; Matthes S; Sykora K; Albert M; O'Meare A; Massaro J; D'Agostino R; Pfitzenmaier M; Sedlacek P; Schlegel P; Arvidson J; Toporski J; Groll A; Fasth A; Winiarski J; Ozsahin H; Schrauder A; Bader P; Hoyle M; Iacobelli M; Dini G; Peters C
Conference publication: BONE MARROW TRANSPLANTATION. 2010;45:S208
Norovirus infections in patients after stem cell transplantation: epidemiological and clinical aspects
Ljungman P; Mattsson J; Winiarski J; Sparrelid E; Ringden O
Conference publication: QUALITY OF LIFE RESEARCH. 2010;19:76
To survey young stem cell transplanted (SCT) patients HRQOL as an intergrated part of the comprehensive care program, can this affect the planning of follow-up care?
Lof CM; Forinder U; Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S241-S242
CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
Avetisyan G; Hagglund H; Hassan Z; LeBlanc K; Mattsson J; Ringden O; Winiarski J; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S371
Subcutaneous immunoglobulin as an alternative route in children after allogenic haematopoietic stem cell transplantation
Jostemyr Y; Nordin K; Hjelt A-C; Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S60
EBV associated PTLD after allogeneic stem cell transplant patients
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Meeting abstract: BLOOD. 2007;110(11):2969-872A
Prospecitve quantitative PCR monitoring of allogeneic stem cell transplant (SCT) patients at high risk for EBV associated PTLD
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski JH; Yun Z; Ljungman PT
Review: PEDIATRIC BLOOD AND CANCER. 2007;48(2):124-131
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter J-I; Horne A; Arico M; Egeler RM; Filipovich AH; Imashuku S; Ladisch S; McClain K; Webb D; Winiarski J; Janka G
Conference publication: PSYCHO-ONCOLOGY. 2007;16(9):S136-S137
Life situation for young adults who have undergone SCT (stem cell transplantation) as children
Forinder U; Lof C; Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 2007;39:S297
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in haematopoietic stem cell transplantation for treatment of non-malignant diseases
Ringden O; Remberger M; Svenberg P; Svahn B; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2006;24(36):5750-5762
Pathways through relapses and deaths of children with acute lymphoblastic leukemia:: Role of allogeneic stem-cell transplantation in Nordic data
Saarinen-Pihkala UM; Heilmann C; Winiarski J; Glomstein A; Abrahamsson J; Arvidson J; Bekassy AN; Forestier E; Jonmundsson G; Schroeder H; Vettenranta K; Wesenberg F; Gustafsson G
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):126
Allogeneic hematopoietic stem cell transplantation for inherited disorders: Experience in a single-center
Mattson J; Remberger M; Svahn BM; Svenberg P; Winiarski J; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2006;37:S204
Safe administration of oral busulphan b.i.d during conditioning for stem cell transplantation in a paediatric population -: a comparative study between the standard 4-dose regimen and a 2-dose regimen
Mellgren K; Nilsson C; Fasth A; Abrahamsson J; Söderhäll S; Winiarski J; Hassan M
Conference publication: BLOOD. 2005;106(11):905A
Fatal infectious complications developing late after allogeneic stem cell transplantation.
Bjorklund A; Aschan J; Ringden O; Winiarski JH; Ljungman PT
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S346
Studies on BIK virus load in urine samples and graft-versus-host disease in relation to risk for development of haemorrhagic cystitis in allogeneic haematopoetic stem cell transplanted patients
Giraud G; Bogdanovic G; Priftakis P; Remberger M; Kokhaei P; Mellstedt H; Ljungman P; Winiarski J; Dalianis T
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S27
Risk factors for development of CMV disease after allogeneic stem cell transplantation in the era of viral load monitoring
Ljungman P; Pérez-Bercoff L; Jonsson J; Sparrelid E; Aschan J; Barkholt L; Larsson K; Lewensohn-Fuchs I; Winiarski J; Yun Z; Ringdén O
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S267
Allogeneic haematopoietic stem cell transplantation for metabolic disorders, a single-centre experience
Ringden O; Remberger M; Svahn B; Barkholt L; Aschan J; Mattsson J; Le Blanc K; Gustafsson B; Hassan Z; Svenberg P; Solders G; von Dobeln U; Winiarski J; Ljungman P; Malm G
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S201
A high BK virus load in urine samples combined with graft-versus-host disease frequently precedes and may predict a risk for haemorrhagic cystitis in haematopoietic stem cell transplanted patients
Bogdanovic G; Priftakis P; Giraud G; Kuzniar M; Kokhaei P; Mellstedt H; Remberger M; Ljungman P; Winiarski J; Dalianis T
Conference publication: PEDIATRIC RESEARCH. 2003;53(4):293A
Bone marrow transplantation in chronic granulomatous disease - A comparison with conventional treatment and a presentation of two new cases
Ahlin A; Ringden O; Winiarski J
Conference publication: BLOOD. 2003;102(11):707A
Correlation between busulphan concentration and transplantation related toxicity in patients undergoing SCT.
Hassan M; Aschan J; Hassan Z; Ringden O; Winiarski J; Ljungman P; Oberg G
Conference publication: BLOOD. 2002;100(11):41A
Hematopoietic stem cell transplantation in 90 children with hemophagocytic lymphohistiocytosis (HLH): Results of the HLH-94 study.
Henter JI; Horne A; Arico M; Egeler M; Gadner H; Imashuku S; Janka G; Ladisch S; Montgomery SM; Webb D; Winiarski J; Filipovich A
Conference publication: BLOOD. 2000;96(11):388A
Phase I clinical trial of liposomal busulphan.
Hassan M; Nilsson C; Ljungman P; Hassau Z; Ringdén O; Hentschke P; Winiarski J; Aschan J
Conference publication: BLOOD. 2000;96(11):387A
Pharmacokinetics of liposomal busulfan in man.
Hassan Z; Ljungman P; Ringdén O; Winiarski J; Nilsson C; Aschan J; Whitley HR; Hassan M
Published conference paper: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS, SUPPLEMENT. 1998;87:54-56
Mechanisms in childhood idiopathic thrombocytopenic purpura (ITP)
Winiarski J
Published conference paper: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS, SUPPLEMENT. 1998;87:51-53
Measurement of platelet antibodies: where do we stand?
Winiarski J
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S32
Low incidence of acute graft-versus-host disease, using unrelated HLA-A, -B, and -DR identical donors and conditioning, including anti-T-cell antibodies.
Ringden O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lonnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S217
EBV-associated lymphomas of different origin in two children after T-cell depleted bone marrow transplantation.
Gustafsson Å; Winiarski J; Ringdén O; Mattson J; Dalianis T; Christensson B
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S184
Post-BMT monitoring of 40 patients by PCR-amplification of immunomagnetically immobilized cells to detect minimal residual disease.
Mattsson J; Zetterquist H; Tammik L; Uzunel M; Winiarski J; Ringdén O
Conference publication: BLOOD. 1998;92(10):653A
Adoptive transfer of Epstein-Barr virus specific cytotoxic T-cells to patients at risk for posttransplant lymphoproliferative disease reduces the EBV DNA load in peripheral blood lymphocytes (PBL).
Gustafsson Å; Levitsky V; Zou JZ; Winiarski J; Frisan T; Ljungman P; Dalianis T; Ringdén O; Ernberg I; Masucci MG
Conference publication: BLOOD. 1998;92(10):357B
Results of bone marrow transplantation in Ph+ all using related or unrelated HLA-A, -B and -DR identical donors.
Larsson K; Lonnqvist B; Winiarski J; Ringdén O; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S119
Clinical effects of intravenous immune globulin treatment after bone marrow transplantation, using HLA matched unrelated donors
Klaesson S; Hagglund H; Ljungman P; Carlens S; Mattsson J; Remberger M; Sparrelid E; Winiarski J; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S2
Results of bone marrow transplantation in Ph+ ALL using related or unrelated HLA-A, -B and -DR identical donors
Larsson K; Winiarski J; Lonnqvist B; Ringden O; Ljungman P
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(1-2):735-736
A low incidence of grade II to IV acute GVHD, but high mortality from, infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate
Mattsson J; Ringden O; Aschan J; Barkholt L; Dalianis T; Hagglund H; Ljungman P; Lonnqvist B; Tollemar J; Winiarski J; Remberger M
Conference publication: BRAIN PATHOLOGY. 1997;7(4):1348
Treatment of adrenoleukodystrophy with bone marrow transplantation
Malm G; Ringden O; Anvret W; vonDobeln U; Hagenfeldt L; Isberg B; Knuutila S; Nennesmo I; Winiarski J; Marcus C
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;17:S62-S64
Transplantation of peripheral blood progenitor cells from unrelated donors
Ringden O; Potter MN; Oakhill A; Cornish J; Hagglund H; Lonnqvist B; Shanwell A; Winiarski J; Pamphilon DH
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3535
No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation
Hagglund H; Ringden O; Ljungman P; Winiarski J; Ericzon B; Tyden G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3530
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation
Sparrelid E; Hagglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringden O
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3528-3529
Less acute GVHD in patients receiving totally matched transplants from unrelated donors
Lonnqvist B; Ljungman P; Norrby M; Olerup O; Ringden O; Winiarski J
Other: BONE MARROW TRANSPLANTATION. 1995;15(5):799-801
BONE-MARROW TRANSPLANTATION IN 2 CHILDREN WITH CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA
HENTER JJ; WINIARSKI J; LJUNGMAN P; RINGDEN O; OST A
Show more

Articles

All other publications

News from KI

Events from KI